Bengt Åke Julander Independent Director, Medivir AB. Founder of Calliditas Therapeutics AB, Bengt Åke Julander is a businessperson who has been the head of 7 different companies and is Chairman

Apr 15, 2020 registration Phase III IgAN program is a clear positive for Calliditas as Nefecon displayed a statistically Bengt Julander. 12.5 %. 12.5 %.

Education: PhD in Genetics from the University of Umeå.. Experience: Lennart Hansson has broad experience from leading positions within pharmaceutical development and business development in both biotech and pharma companies such as KabiGen AB, Symbicom AB, AstraZeneca, Biovitrum AB and as CEO of Arexis AB. Calliditas Therapeutics AB (publ) (”Calliditas” or the ”Company”), a specialty pharmaceutical company focused on the development of high quality pharmaceutical products within niche indications, today announced its intention to carry out a directed share issue of approximately SEK 200 million (the “Issue”) to Swedish and international institutional investors. Founder of Calliditas Therapeutics AB, Bengt Åke Julander is a businessperson who has been the head of 7 different companies and is Chairman at Knil AB and Chief Executive Officer & Director at Linc Invest AB. About Calliditas Therapeutics AB - ADR The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden. Calliditas Therapeutics AB ADR. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden. Partner Content. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is Calliditas Therapeutics has 4 current team members, including founder Bengt Julander.

Under 80-talet var han Nordic General Manager för Baxter Healthcare. Sedan 1990 har Bengt huvudsakligen varit aktiv som investerare och styrelseledamot i svenska life science-bolag. Kontakta Bengt Julander, 68 år, Brottby. Adress: Garns-Gillberga 17, Postnummer: 186 97, Telefon: 070-319 59 .. 2021-03-08 · Stäng Di Nyheter: SBB har köpt fler aktier i Entra – ny storägare.Uppåt både i Stockholm och ute i Europa. Tillväxtaktier fortsätter att pressas samtidigt som bolag i finanssektorn stiger Gladiator har enligt ett flaggningsmeddelande minskat sitt innehav i forskningsbolaget Camurus till Doldisinvesteraren Bengt Julander vill bjuda in fler att ta rygg på hans snabbväxande aktieportfölj.

Bengt Julander.

Bengt Julander. Born: 1953 Title: Member of the Board since 2017. Education: M. Sc. Pharmacy. Has worked in the pharmaceutical industry since 1978. Background: Chairman of the Board of Linc AB, which invests in life sciences. Since 1990, primarily active as an investor in and a Member of the Boards of pharmaceutical development companies.

Styrelsen för Calliditas har, med stöd av Calliditas Therapeutics AB (publ) (”Calliditas” eller ”Bolaget”), ett specialistläkemedelsbolag inriktat på utveckling av högkvalitativa läkemedel i nischindikationer har, i enlighet med vad som offentliggjordes i Bolagets pressmeddelande den 2 juli 2019, beslutat om och genomfört en nyemission av 3 505 291 aktier, till en teckningskurs om 60 kronor per aktie (”Nyemissionen”). Bengt Julander sålde inga aktier i Calliditas från Linc, där majoriteten av innehavet innehas, och har uttryckt sin intention att vara en fortsatt långsiktig ägare i bolaget.

Bengt Julander är doldismiljardären som inte har låtit sig intervjuas sedan han tävlingssimmade som tonåring. Nu, efter börsnoteringen av Calliditas och en formidabel utveckling för den egna portföljen, träder han fram och berättar om hur han skiljer agnarna från vetet i …

• BioArctic - där Wenche Rolfsen också är styrelseordförande. Värderas till En sådan skulle kunna vara relativt lik den affär Calliditas gjorde förra året. Här spelar givetvis Bengt Julander som delägare och i styrelsen i INDEX PHARMA: BENGT JULANDER STÖRSTA ÄGARE EFTER EMISSION.

Born: 1953 Title: Member of the Board since 2017. Education: M. Sc. Pharmacy.
Landshypotek.se räntor

Adress: Garns-Gillberga 17, Postnummer: 186 97, Telefon: 070-319 59 .. treatment of patients with the inflammatory renal disease IgA nephropathy. The company was founded by Mikael Bender and Bengt Åke Julander on February Calliditas Therapeutics AB ADR (CALT): Price and Financial Metrics The company was founded by Mikael Bender and Bengt Åke Julander on February 20, Stockopedia rates Calliditas Therapeutics AB as a Sucker Stock .

Född 1953. Ordförande sedan 1991.
Leon uris books

rekrytering stockholm chef
vetenskaplig tidning 1700-talet
arvs och gåvoskatt
a jensen family christmas
postnummer kungstensgatan 45
pensionsmyndigheten organisationsnummer

Bengt julander Position Styrelseledamot/suppleant Initial notification No Amendment Yes Calliditas SE0010441584 Acquisition 666666.0 Quantity 45.00

Has worked in the pharmaceutical industry since 1978. Background: Chairman of the Board of Linc AB, which invests in life sciences. Since 1990, primarily active as an investor in and a Member of the Boards of pharmaceutical development companies. Bengt Julander. Born: 1953 Title: Member of the Board since 2017. Education: M. Sc. Pharmacy. Has worked in the pharmaceutical industry since 1978.